About Sosum PCL Solution®
Sosum PCL Solution® is an innovative collagen biostimulating product developed by Sosum Global, a South Korean medical aesthetics manufacturer specializing in advanced regenerative injectables. Utilizing polycaprolactone (PCL) microspheres suspended in a sterile carrier, this solution is designed for professional use in aesthetic clinics to rebuild skin structure, restore volume, and enhance texture over time. PCL’s unique degradability profile supports a slow-release mechanism, providing both immediate and sustained lifting and rejuvenation effects.
Sosum PCL Solution® Features
PCL microspheres offer durable collagen stimulation through their longer biodegradation rate compared to other biostimulators like PLLA or PDLLA. Once injected, the carrier gel provides an initial volumizing effect, while the PCL particles gradually promote neocollagenesis, resulting in firmer, more youthful skin. With effects building progressively and lasting up to three years, the formulation gives practitioners a versatile, long-term anti-aging option with excellent tolerability and integration into tissue.
Available in pre-mixed syringes ready for injection, the solution is intended for areas with volume loss, facial sagging, and skin laxity, such as cheeks, jawline, temples, and marionette lines. Its dual-phase action—immediate volumization followed by deep dermal remodeling—makes it suitable for comprehensive rejuvenation protocols with minimal downtime.
About Sosum Global
Sosum Global is a dynamic innovator in aesthetic medicine devoted to developing science-based, regenerative injectables. With a focus on synthesis of biomaterials and clinical efficacy, Sosum Global creates advanced solutions like the Sosum PCL Solution® to meet evolving needs in skin correction and facial contouring. Adhering to strict quality standards and leveraging Korean cosmetic science, the company empowers practitioners globally with durable, high-performance aesthetic tools.